When completed in 2005, the laboratory will contain approximately
38,000 GSF of high containment BSL3Ag and BSL4 laboratory and
vivarium space as well as approximately 42,000 GSF of BSL3 and
BSL2 laboratory, office and other building support space. The project
also includes additions to an existing campus utility and central plant
infrastructure to support the new laboratory.
This world-class infectious disease biomedical research containment
facility is to serve as the cornerstone for the long-term master plan
initiatives for the Rocky Mountain Laboratory Campus. The facility
is being designed to allow research on known, as well as emerging and
unknown diseases. A component of the design will address the need
for biological terrorism preparedness.
As Development Manager, Higgins Development Partners is acting as
the single point of responsibility and accountability for all aspects of
programming, facilities design and construction.